Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Leases (2022 - 2025)

Historic Current Leases for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $436000.0.

  • Praxis Precision Medicines' Current Leases fell 6437.91% to $436000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $436000.0, marking a year-over-year decrease of 6437.91%. This contributed to the annual value of $1.3 million for FY2024, which is 1181.17% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Current Leases stood at $436000.0, which was down 6437.91% from $755000.0 recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Current Leases high stood at $1.3 million for Q4 2024, and its period low was $436000.0 during Q3 2025.
  • Moreover, its 4-year median value for Current Leases was $1.1 million (2023), whereas its average is $1.0 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 1211.8% in 2023, then crashed by 6437.91% in 2025.
  • Over the past 4 years, Praxis Precision Medicines' Current Leases (Quarter) stood at $1.0 million in 2022, then grew by 12.04% to $1.1 million in 2023, then rose by 11.81% to $1.3 million in 2024, then plummeted by 65.37% to $436000.0 in 2025.
  • Its last three reported values are $436000.0 in Q3 2025, $755000.0 for Q2 2025, and $1.1 million during Q1 2025.